These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Ichthyosis bullosa of Siemens: its correct diagnosis facilitated by molecular genetic testing. Akiyama M; Tsuji-Abe Y; Yanagihara M; Nakajima K; Kodama H; Yaosaka M; Abe M; Sawamura D; Shimizu H Br J Dermatol; 2005 Jun; 152(6):1353-6. PubMed ID: 15949009 [TBL] [Abstract][Full Text] [Related]
31. Use of the frozen section 'jelly-roll' technique to aid in the diagnosis of bullous congenital ichthyosiform erythroderma (epidermolytic hyperkeratosis). Galler B; Bowen C; Arnold J; Kobayashi T; Dalton SR J Cutan Pathol; 2016 May; 43(5):434-7. PubMed ID: 26969483 [TBL] [Abstract][Full Text] [Related]
32. A novel leucine to valine mutation in residue 7 of the helix initiation motif of keratin10 leads to bullous congenital ichthyosiform erythroderma. Ishiko A; Akiyama M; Takizawa Y; Nishikawa T; Shimizu Y; Shimizu H J Invest Dermatol; 2001 Jun; 116(6):991-2. PubMed ID: 11407994 [No Abstract] [Full Text] [Related]
33. An asparagine to threonine substitution in the 1A domain of keratin 1: a novel mutation that causes epidermolytic hyperkeratosis. Arin MJ; Longley MA; Küster W; Huber M; Hohl D; Rothnagel JA; Roop DR Exp Dermatol; 1999 Apr; 8(2):124-7. PubMed ID: 10232403 [TBL] [Abstract][Full Text] [Related]
34. A transgenic mouse model that recapitulates the clinical features of both neonatal and adult forms of the skin disease epidermolytic hyperkeratosis. Bickenbach JR; Longley MA; Bundman DS; Dominey AM; Bowden PE; Rothnagel JA; Roop DR Differentiation; 1996 Dec; 61(2):129-39. PubMed ID: 8983179 [TBL] [Abstract][Full Text] [Related]
35. The molecular genetics of keratin disorders. Smith F Am J Clin Dermatol; 2003; 4(5):347-64. PubMed ID: 12688839 [TBL] [Abstract][Full Text] [Related]
36. DNA-based prenatal exclusion of bullous congenital ichthyosiform erythroderma at the early stage, 10 to 11 weeks' of pregnancy, in two consequent siblings. Tsuji-Abe Y; Akiyama M; Nakamura H; Takizawa Y; Sawamura D; Matsunaga K; Suzumori K; Shimizu H J Am Acad Dermatol; 2004 Dec; 51(6):1008-11. PubMed ID: 15583602 [TBL] [Abstract][Full Text] [Related]
37. Epidermolytic hyperkeratosis type NPS-3: a case report. Prohić A; Selmanagić A; Bilalović N Acta Dermatovenerol Croat; 2007; 15(1):20-3. PubMed ID: 17433175 [TBL] [Abstract][Full Text] [Related]
38. A novel mutation in the L12 domain of keratin 1 is associated with mild epidermolytic ichthyosis. Bolling MC; Bladergroen RS; van Steensel MA; Willemsen M; Jonkman MF; van Geel M Br J Dermatol; 2010 Apr; 162(4):875-9. PubMed ID: 20500210 [TBL] [Abstract][Full Text] [Related]
39. Mutations in the 1A domain of keratin 9 in patients with epidermolytic palmoplantar keratoderma. Rothnagel JA; Wojcik S; Liefer KM; Dominey AM; Huber M; Hohl D; Roop DR J Invest Dermatol; 1995 Mar; 104(3):430-3. PubMed ID: 7532199 [TBL] [Abstract][Full Text] [Related]
40. Ultrastructural changes resulting from keratin-9 gene mutations in two families with epidermolytic palmoplantar keratoderma. Navsaria HA; Swensson O; Ratnavel RC; Shamsher M; McLean WH; Lane EB; Griffiths D; Eady RA; Leigh IM J Invest Dermatol; 1995 Mar; 104(3):425-9. PubMed ID: 7532198 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]